Diabetes in pregnancy: health risks and management
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Diabetes in pregnancy is increasing and therefore it is important to raise awareness of the associated health risks to the mother, the growing fetus, and the future child. Perinatal mortality and morbidity is increased in diabetic pregnancies through increased stillbirths and congenital malformation rates. These are mainly the result of early fetal exposure to maternal hyperglycaemia. In the mother, pregnancy may lead to worsening or development of diabetic complications such as retinopathy, nephropathy, and hypoglycaemia. This review defines pregestational and gestational diabetes and the associated health risks to the growing fetus and mother. Management is discussed, focusing on clinical evidence based guidelines published by the American Diabetic Association and the UK National Institute for Health and Clinical Excellence on the management of pregnant women with pre-existing diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390
Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis
Bellamy, L., Casas, J.-P., Hingorani, A. D., & Williams, D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60731-5 · Cited by 3,253 · cited 1×
“51).(103) The risk of progression to diabetes varies with ethnic background, obesity and postpartum weight gain, family history of diabetes, and whether insulin was required during the antenatal period.”
BackgroundMetzger, B. E., Buchanan, T. A., Coustan, D. R., de Leiva, A., Dunger, D. B., Hadden, D. R., Hod, M., Kitzmiller, J. L., Kjos, S. L., Oats, J. N., et al. (2007) · Diabetes Care · doi:10.2337/dc07-s225 · Cited by 1,908
Metzger, B. E., Gabbe, S. G., Persson, B., Lowe, L. P., Dyer, A. R., Oats, J. J. N., & Buchanan, T. A. (2010) · Diabetes Care · doi:10.2337/dc10-0719 · Cited by 1,888
Buchanan, T. A., Xiang, A. H., Peters, R. K., Kjos, S. L., Marroquin, A., Goico, J., Ochoa, C., Tan, S., Berkowitz, K., Hodis, H. N., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2796 · Cited by 1,339
Metformin versus insulin for the treatment of gestational diabetes
Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R., & Moore, M. P. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707193 · Cited by 1,291 · cited 1×
“Although the ADA currently does not recommend the use of metformin it does for glibenclamide,(5) while NICE supports the use of both(3) following results of two randomised control trials.(95) 96”
BackgroundDabelea, D., Hanson, R. L., Lindsay, R. S., Pettitt, D. J., Imperatore, G., Gabir, M. M., Roumain, J., Bennett, P. H., & Knowler, W. C. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2208 · Cited by 1,277
Major congenital malformations after first-trimester exposure to ACE inhibitors
Cooper, W. O., Hernandez-Diaz, S., Arbogast, P. G., Dudley, J. A., Dyer, S., Gideon, P. S., Hall, K., & Ray, W. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055202 · Cited by 1,192
Cryer, P. E., Davis, S. N., & Shamoon, H. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1902 · Cited by 1,160 · cited 1×
“This early increase in sensitivity coincides with a physiological fall in fasting blood glucose and a decrease in counter-regulatory hormones to hypoglycaemia.”
BackgroundA comparison of glyburide and insulin in women with gestational diabetes mellitus
Langer, O., Conway, D. L., Berkus, M. D., Xenakis, E. M.-J., & Gonzales, O. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431601 · Cited by 924 · cited 1×
“following results of two randomised control trials.”
Kurtzhals, P., Schäffer, L., Sørensen, A., Kristensen, C., Jonassen, I., Schmid, C., & Trüb, T. (2000) · Diabetes · doi:10.2337/diabetes.49.6.999 · Cited by 739 · cited 1×
“Basal analogue insulin is not currently recommended by the ADA or NICE. Theoretical concerns around potential mitogenicity with glargine exists”
BackgroundClausen, T. D., Mathiesen, E. R., Hansen, T., Pedersen, O., Jensen, D. M., Lauenborg, J., & Damm, P. (2008) · Diabetes Care · doi:10.2337/dc07-1596 · Cited by 724
Macintosh, M. C. M., Fleming, K. M., Bailey, J. A., Doyle, P., Modder, J., Acolet, D., Golightly, S., & Miller, A. (2006) · BMJ · doi:10.1136/bmj.38856.692986.ae · Cited by 673
Hirsch, I. B. (2005) · New England Journal of Medicine · doi:10.1056/nejmra040832 · Cited by 667
de Veciana, M., Major, C. A., Morgan, M. A., Asrat, T., Toohey, J. S., Lien, J. M., & Evans, A. T. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511093331901 · Cited by 666 · cited 1×
“to assess insulin requirements. A 1 h postprandial glucose reading rather than a preprandial glucose reading has been shown to be associated with a fewer number of large for gestational age (LGA) babies, caesarean sections for cephalo-pelvic disproportion, and episodes of neonatal hypoglycaemia.”
BackgroundFetuses of obese mothers develop insulin resistance in utero
Catalano, P. M., Presley, L., Minium, J., & Hauguel-de Mouzon, S. (2009) · Diabetes Care · doi:10.2337/dc08-2077 · Cited by 655 · cited 1×
“Obese mothers are at added risk of birth trauma from an LGA baby—that is, those babies with birth weights above the 90th centile—with these LGA infants being at long term risk of future obesity and diabetes.”
BackgroundCongenital susceptibility to NIDDM. Role of intrauterine environment
Pettitt, D. J., Aleck, K. A., Baird, H. R., Carraher, M. J., Bennett, P. H., & Knowler, W. C. (1988) · Diabetes · doi:10.2337/diab.37.5.622 · Cited by 530
Managing preexisting diabetes for pregnancy
Kitzmiller, J. L., Block, J. M., Brown, F. M., Catalano, P. M., Conway, D. L., Coustan, D. R., Gunderson, E. P., Herman, W. H., Hoffman, L. D., Inturrisi, M., et al. (2008) · Diabetes Care · doi:10.2337/dc08-9020 · Cited by 476
Diabetes Control and Complications Trial Research Group (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1084 · Cited by 385
Recurrence of Gestational Diabetes Mellitus
Kim, C., Berger, D. K., & Chamany, S. (2007) · Diabetes Care · doi:10.2337/dc06-2517 · Cited by 367
Hawthorne, G., Robson, S., Ryall, E. A., Sen, D., Roberts, S. H., & Platt, M. P. W. (1997) · BMJ · doi:10.1136/bmj.315.7103.279 · Cited by 276
Peters, R. K., Xiang, A., Kjos, S. L., & Buchanan, T. A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90405-5 · Cited by 273 · cited 1×
“< Parity in Latin American women.(112) < Lifestyle intervention, metformin and thiazolidinediones have”
BackgroundHigh Prevalence of Gestational Diabetes in Women from Ethnic Minority Groups
Dornhorst, A., Paterson, C. M., Nicholls, J. S. D., Wadsworth, J., Chiu, D. C., Elkeles, R. S., Johnston, D. G., & Beard, R. W. (1992) · Diabetic Medicine · doi:10.1111/j.1464-5491.1992.tb01900.x · Cited by 263
Self-citationIncreasing Incidence of Diabetes After Gestational Diabetes
Lauenborg, J., Hansen, T., Jensen, D. M., Vestergaard, H., Mølsted-Pedersen, L., Hornnes, P., Locht, H., Pedersen, O., & Damm, P. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1194 · Cited by 257 · cited 2×
“Diabetes following GDM Both GDM and T2DM share common diabetic risk alleles(97) and have similar insulin secretory defects(98) and risk factors.(99) Hence, women who develop GDM are at risk of developing T2DMdthe exception being a few women with GDM who are in the preclinical phase of T1DM or with rarer forms of diabe…”
BackgroundPredictors of postpartum diabetes in women with gestational diabetes mellitus
Löbner, K., Knopff, A., Baumgarten, A., Mollenhauer, U., Marienfeld, S., Garrido-Franco, M., Bonifacio, E., & Ziegler, A.-G. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-0746 · Cited by 234
Jensen, D. M., Korsholm, L., Ovesen, P., Beck-Nielsen, H., Moelsted-Pedersen, L., Westergaard, J. G., Moeller, M., & Damm, P. (2009) · Diabetes Care · doi:10.2337/dc08-2061 · Cited by 227
Pregnancy outcome in type 1 diabetic women with microalbuminuria
Ekbom, P., Damm, P., Feldt-Rasmussen, B., Feldt-Rasmussen, U., Mølvig, J., & Mathiesen, E. R. (2001) · Diabetes Care · doi:10.2337/diacare.24.10.1739 · Cited by 224
Guerin, A., Nisenbaum, R., & Ray, J. G. (2007) · Diabetes Care · doi:10.2337/dc07-0278 · Cited by 215
Breast-Feeding and Risk for Childhood Obesity
Mayer-Davis, E. J., Rifas-Shiman, S. L., Zhou, L., Hu, F. B., Colditz, G. A., & Gillman, M. W. (2006) · Diabetes Care · doi:10.2337/dc06-0974 · Cited by 212
Hypoglycemia in Pregnant Women With Type 1 Diabetes
Nielsen, L. R., Pedersen-Bjergaard, U., Thorsteinsson, B., Johansen, M., Damm, P., & Mathiesen, E. R. (2008) · Diabetes Care · doi:10.2337/dc07-1066 · Cited by 204 · cited 1×
“Women with T1DM are extremely susceptible to hypoglycaemia, especially during the first 22 weeks of pregnancy when insulin sensitivity actually increases before decreasing in the second trimester.”
BackgroundFarrar, D., Tuffnell, D. J., West, J., & West, H. M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005542.pub3 · Cited by 194
Buchanan, T. A., Kjos, S. L., Montoro, M. N., Wu, P. Y. K., Madrilejo, N. G., Gonzalez, M., Nunez, V., Pantoja, P. M., & Xiang, A. (1994) · Diabetes Care · doi:10.2337/diacare.17.4.275 · Cited by 186 · cited 1×
“typically present as serial fetal abdominal circumference measurements that cross centile lines.(47) 48 Table 3 Achieving good glycaemic control in pregnancy”
BackgroundProgression of diabetic retinopathy in pregnancy: association with hypertension in pregnancy
Rosenn, B., Miodovnik, M., Kranias, G., Khoury, J., Combs, C. A., Mimouni, F., Siddiqi, T. A., & Lipman, M. J. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(11)90608-5 · Cited by 169 · cited 1×
“66 Good blood pressure and glycaemic control both lessen retinopathy progression.(67) The screening and management of diabetic retinopathy in pregnancy is outlined in box 7.”
BackgroundROSENN, B., MIODOVNIK, M., HOLCBERG, G., KHOURY, J., & SIDDIQI, T. (1995) · Obstetrics & Gynecology · doi:10.1016/0029-7844(94)00415-a · Cited by 161
Mukhopadhyay, A., Farrell, T., Fraser, R. B., & Ola, B. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.03.062 · Cited by 153
Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy
Murphy, H. R., Rayman, G., Duffield, K., Lewis, K. S., Kelly, S., Johal, B., Fowler, D., & Temple, R. C. (2007) · Diabetes Care · doi:10.2337/dc07-0500 · Cited by 138
Fetal plasma erythropoietin in pregnancies complicated by maternal diabetes mellitus
Salvesen, D. R., Michael Brudenell, J., Snijders, R. J. M., Ireland, R. M., & Nicolaides, K. H. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(12)90891-1 · Cited by 105
Mathiesen, E. R., Christensen, A. L., Hellmuth, E., Hornnes, P., Stage, E., & Damm, P. (2002) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.2002.810906.x · Cited by 100
Damm, P., Kühl, C., Buschard, K., Jakobsen, B. K., Svejgaard, A., Sodoyez‐Goffaux, F., Shattock, M., Bottazzo, G. F., & Mølsted‐Pedersen, L. (1994) · Diabetic Medicine · doi:10.1111/j.1464-5491.1994.tb02035.x · Cited by 81
Feldberg, D., Dicker, D., Samuel, N., Peleg, D., Karp, M., Goldman, J. A., & Goldman, J. A. (1988) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.3109/00016348809004231 · Cited by 33
Cited by
(2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.10.012 · Cited by 914
Recent advances on the development of wound dressings for diabetic foot ulcer treatment—A review
Moura, L. I. F., Dias, A. M. A., Carvalho, E., & de Sousa, H. C. (2013) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.03.033 · Cited by 778
Colagiuri, S., Falavigna, M., Agarwal, M. M., Boulvain, M., Coetzee, E., Hod, M., Meltzer, S. J., Metzger, B., Omori, Y., Rasa, I., et al. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.02.012 · Cited by 132
“The recommendation for a distinct category for pregnant women with glucose levels diagnostic of diabetes in nonpregnant adults is based on the significant risk of adverse obstetric, diabetes and perinatal outcomes [5] which are comparable to women with type 2 diabetes diagnosed prior to pregnancy [6,7].”
BackgroundJiang, L., Gao, C., Yan, P., Chen, P., Jiang, C., Xu, Y., & Chen, M. (2022) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1814239 · Cited by 16
Retracted
Metadata
- Authors
- Ali, S., & Dornhorst, A.
- Venue
- Postgraduate Medical Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-03-02
- Volume
- 87
- Issue
- 1028
- Pages
- 417-427
- ISSN
- 0032-5473 (ISSN-L)
- 1469-0756
- OpenAlex
- W2167702686
- Cited by
- 89
- References
- 41
- FWCI
- 12.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.